Geographic Variation in the Utilization of Noninvasive Diagnostic Imaging: National Medicare Data, 1998–2007
Abstract
OBJECTIVE. This study provides an overview of geographic variation in noninvasive diagnostic imaging utilization in the Medicare population over the period 1998 to 2007.
MATERIALS AND METHODS. The Centers for Medicare and Medicaid Services Physician Supplier Procedure Summary Master Files for 1998–2007 were the primary data source for the study. Physician Supplier Procedure Summary Master Files are an aggregation of the complete Part B Medicare billing records for all 32–37 million fee-for-service beneficiaries and provide the total number of each type of procedure performed, categorized by geographic regions. For the 10 Centers for Medicare and Medicaid Services geographic regions, we calculated the overall noninvasive diagnostic imaging procedure utilization rate and the ratio of the highest to lowest region (a relative risk statistic) for each year of the study. For the first and last years of the study, we calculated these numbers for 28 noninvasive diagnostic imaging categories.
RESULTS. In 2007, the Atlanta region had the highest utilization rate, with 4.60 procedures per capita, and Seattle had the lowest rate, with 2.99 procedures per capita. The relative risk was 1.54. Over the 10 years of the study, there was little change in the relative utilization rates of regions, and the relative risk ranged between 1.47 and 1.56. In 2007, bone densitometry showed the lowest regional relative risk (1.29), and cardiovascular PET showed the highest regional relative risk (70.2). Cardiovascular noninvasive diagnostic imaging and high-technology, high-cost noninvasive diagnostic imaging (e.g., MRI, PET, and nuclear medicine) showed high regional relative risk.
CONCLUSION. Regional variation is substantial—about 50% higher in the highest regions than in the lowest regions—but is not huge. Regional variation is increasing slightly. Cardiovascular and high-technology procedures show the greatest regional variation.
Introduction
Concern about the rising cost of healthcare is now a central issue in the American economy. Radiology procedures have come under increasing scrutiny since the Medicare Payment Advisory Commission identified imaging as showing the “highest cumulative growth in services per beneficiary” in recent years [1]. Noninvasive diagnostic imaging procedures are widely used procedures, and the accelerating development and use of high-technology imagery (e.g., CT, MRI, and PET) involves high costs. In an earlier study [2], we discussed the increasing use of noninvasive diagnostic imaging and high-cost techniques. The Deficit Reduction Act of 2005 [3] attempted to rein in radiology costs by reducing reimbursements to private offices for high-technology, high-cost procedures, such as MRI and CT. A Government Accountability Office report in 2008 [4] showed Medicare Part B imaging spending more than doubling, from $6.89 to $14.11 billion, between 2000 and 2006.
The New York Times reports intense interest on the part of the president and policy makers in “huge geographic variations in Medicare spending per beneficiary” [5]. A recent study by Iglehart [6] cites the Government Accountability Office's finding of nearly eight-fold variation among states in Medicare imaging expenditures, from $62 per capita in Vermont to $472 per capita in Florida.
The study of geographic variation in disease incidence was a foundation of modern epidemiology [7, 8]. Currently, the Dartmouth Atlas project [9] provides a wealth of information about geographic variation in health care utilization in the United States.
This study provides a comprehensive overview of geographic variation in noninvasive diagnostic imaging utilization in the Medicare population. To our knowledge, this type of overview has not been published before. There have been a number of more limited studies of geographic variation in noninvasive diagnostic imaging. Not surprisingly, the most frequently studied area has been breast cancer screening [10–15]. There have been several geographic studies of other cancer screening and staging examinations [16–19], spinal imaging [20], cardiac noninvasive diagnostic imaging [21, 22], and neurologic noninvasive diagnostic imaging [23]. Only one study [24] attempted a broad survey of geographic variation over the entire spectrum of imaging procedures. However, it reported data only to 2001, categorized noninvasive diagnostic imaging only according to technique, and reported statewide findings by percentile ranks, which are hard to interpret.
In this study, we are concerned with three questions: First, are utilization rates similar or dissimilar across geographic regions? Second, do trends in utilization from 1998 to 2007 differ among regions? Third, do rates and trends vary among procedure categories across regions?
Materials and Methods
The primary data sources for this study were the Centers for Medicare and Medicaid Services Part B Physician Supplier Procedure Summary Master Files for 1998–2007. These files aggregate Medicare Part B billing claims filed by physicians nationally for all procedures. The billing claims are classified by codes for the type of procedure, region, place of service, and specialty of the providing physician. Both the number of procedures performed and the allowed charges for each category are available. These databases are anonymous public use files and are exempt from review by institutional review boards.

The files cover all Medicare fee-for-service beneficiaries but do not include patients enrolled in managed care plans. Total Medicare enrollment ranged from 38.5 million beneficiaries in 1998 to 45.7 million in 2007. The percentage of healthcare maintenance organization enrollees was 17.2% in 1998, declined to 12.7% in 2004, and increased again to 19.2% in 2007. Therefore, the number of individuals covered by the data sets ranged from 31.9 million in 1998 to 36.9 million in 2007, with a peak of 37.8 million in 2004.
We evaluated all current procedural terminology codes related to noninvasive diagnostic imaging, which were selected from the fourth edition of Current Procedural Terminology for 1998–2007 [25]. These codes are designated by the American Medical Association and are referred to by Centers for Medicare and Medicaid Services as “CPT-4” or “level 1 Healthcare Common Procedure Coding System” codes. Noninvasive diagnostic imaging codes used for this evaluation included most codes in the 70,000 series (which are generally thought of as constituting radiology) and the cardiac and vascular sonography procedures listed in the 90,000 series. This analysis excluded surgical codes, the radiologic supervision and interpretation codes that accompany them, radiation oncology procedure codes, 3D reconstruction codes, and radioimmunoassay codes. Obstetric ultrasound was included in this analysis, although it is underrepresented in the Medicare population. We also included the imaging-related level 2 Healthcare Common Procedure Coding System codes [26], which are five-position alphanumeric codes approved and maintained jointly by the alphanumeric editorial panel (consisting of Centers for Medicare and Medicaid Services, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). These alphanumeric codes are sometimes used for gathering utilization data and setting reimbursement of procedures before the establishment of a current procedural terminology code by the American Medical Association.
The total number of codes studied in each year varied as a result of the creation of new codes and discontinuation of outdated codes. There were 412 noninvasive diagnostic imaging codes in 1998 and 575 such codes in 2007. For the analyses in this article, we aggregated these codes into 28 categories, reflecting both technique and anatomic location. The number of codes in each category ranged from one for breast ultrasound to 95 for skeletal radiography. Three of the categories—CT cardiac, CT vascular, and PET head, did not exist in all the years of the study.
We used Centers for Medicare and Medicaid Services region codes for the geographic analysis. Ten regional codes (Fig. 1) are named for the city in which the Centers for Medicare and Medicaid Services regional office is located, as follows: Boston, New York, Philadelphia, Atlanta, Chicago, Dallas, Kansas City (Missouri), Denver, San Francisco, and Seattle. These 10 regions include all 50 states and the territories of the United States. One additional code, “Traveler's Railroad,” which identifies a small percentage of Medicare recipients by miscellaneous categories (e.g., railroad workers) rather than by geographic location, was excluded from the analysis of geographic data.
The regional utilization rate was calculated by determining the number of eligible fee-for-service Medicare beneficiaries for each year in each region. These were obtained by summing the county-level data in the Centers for Medicare and Medicaid Services Medicare Managed Care Market Penetration for All Medicare Plan Contractors—Quarterly State/County Data Files, which list total beneficiaries and health maintenance organization enrollees in each county. Two rate statistics were used: per capita and per 100,000 beneficiciary population.
We calculated overall utilization in each of the 10 Centers for Medicare and Medicaid Services regions for each of the years of our study, as well as the percentage change from 1998 to 2001, 2001 to 2004, 2004 to 2007, and 1998 to 2007. We also calculated the overall utilization rate and percentage change across all regions. Pearson's correlation coefficients (r) were computed for the relationship between the 1998 and 2007 rates to the 10-year rate of change for each region. For each of the 28 procedure categories, we calculated the rate per 100,000 population, determined the region with the highest rate, the region with the lowest rate, and the ratio of the highest to lowest region, which is a relative risk statistic. We also calculated allowed charges and relative value units (a measure of work involved in the procedure) per capita for each region and the high-to-low ratio. We used the total professional component relative value unit from the 2007 files published by the American Medical Association. Relative value unit values for a given procedure may change small amounts from year to year, as the amount of work involved is reevaluated; using the same relative value unit across all years eliminates changes in the relative value units per capita that we calculated that are due to this reevaluation process.

The Medicare Part B database represents the total fee-for-service Medicare population. Because these are complete population counts, no inferential statistics are required, as would be the case if we were trying to infer population statistics from sample data.
Results
Utilization Across All Regions
The dashed line in Figure 2 shows overall noninvasive diagnostic imaging utilization per capita from 1998 to 2007 (the 2007 figures also appear in the regional map shown in Fig. 1). Except for a slight decline from 1998 to 1999, there is a monotonic increase over these years. Overall change for the period was an increase of 29.3%, with much greater growth (13.7%) in the middle 3-year period than the beginning (6.0%) or end (7.3%).
Differences in Overall Utilization Between Regions
Table 1 shows the noninvasive diagnostic imaging utilization rates per capita for the 10 regions for each year from 1998 to 2007. The table is arranged in descending order of utilization rates in 2007. When regions were compared, the differences between them were consistently maintained over the 10-year period. The high region was always Atlanta, the low region was always Seattle, and the relative risk was fairly consistent, from 1.47 to 1.54 over the 10-year period. New York had the greatest growth (34.2%), and San Francisco had the lowest growth rate (23.5%). The fact that relative risks were generally higher in the last 5 years than in the first 5 years indicates that regional utilization disparities did not decrease. The Pearson's correlation coefficients for 1998 and 2007 rates with 10-year rate of change were 0.06 and 0.33, respectively; neither coefficient was significant for 10 data pairs.
Utilization Rate per Capita, by Year | Percentage Change | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Region | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 1998-2001 | 2001-2004 | 2004-2007 | 1998-2007 |
Atlanta | 3.47 | 3.4 | 3.56 | 3.75 | 3.95 | 4.12 | 4.27 | 4.46 | 4.53 | 4.6 | 8.10 | 13.90 | 7.70 | 32.60 |
Dallas | 3.2 | 3.12 | 3.25 | 3.45 | 3.68 | 3.82 | 4.01 | 4.2 | 4.25 | 4.33 | 7.80 | 16.20 | 8.00 | 35.30 |
New York | 3.19 | 3.07 | 3.16 | 3.3 | 3.52 | 3.63 | 3.82 | 3.94 | 4.22 | 4.28 | 3.40 | 15.80 | 12.00 | 34.20 |
Philadelphia | 3.32 | 3.25 | 3.37 | 3.52 | 3.67 | 3.76 | 3.91 | 4.08 | 4.11 | 4.17 | 6.00 | 11.10 | 6.60 | 25.60 |
Chicago | 3.08 | 3.05 | 3.15 | 3.35 | 3.52 | 3.65 | 3.82 | 3.97 | 4.09 | 4.12 | 8.80 | 14.00 | 7.90 | 33.80 |
Kansas City | 2.96 | 2.95 | 3.07 | 3.29 | 3.41 | 3.51 | 3.67 | 3.82 | 3.85 | 3.91 | 11.10 | 11.60 | 6.50 | 32.10 |
Boston | 3.07 | 2.92 | 3.06 | 3.22 | 3.37 | 3.48 | 3.62 | 3.78 | 3.83 | 3.89 | 4.90 | 12.40 | 7.50 | 26.70 |
San Francisco | 3.07 | 2.96 | 3.04 | 3.18 | 3.45 | 3.52 | 3.7 | 3.87 | 3.83 | 3.79 | 3.60 | 16.40 | 2.40 | 23.50 |
Denver | 2.54 | 2.56 | 2.67 | 2.87 | 2.99 | 3.07 | 3.19 | 3.37 | 3.37 | 3.38 | 13.00 | 11.10 | 6.00 | 33.10 |
Seattle | 2.33 | 2.32 | 2.42 | 2.55 | 2.69 | 2.72 | 2.8 | 2.95 | 2.9 | 2.99 | 9.40 | 9.80 | 6.80 | 28.30 |
All regions | 3.17 | 3.1 | 3.21 | 3.36 | 3.55 | 3.66 | 3.82 | 4.03 | 4.06 | 4.1 | 6.00 | 13.70 | 7.30 | 29.30 |
Relative risk (high/low) | 1.49 | 1.47 | 1.47 | 1.47 | 1.47 | 1.51 | 1.53 | 1.51 | 1.56 | 1.54 |
Note—Table rows are ordered by descending 2007 regional noninvasive diagnostic imaging utilization rates per capita.
In Table 2, regional allowed charges and relative value units per capita for 2007 are presented. The relative risk calculated from high-to-low regional allowed charges is 2.20; the relative risk calculated from relative value units is 1.52.
Region | Allowed Charges ($) | Relative Value Units |
---|---|---|
Atlanta | 247 | 3.56 |
New York | 388 | 3.33 |
Dallas | 278 | 3.25 |
Philadelphia | 250 | 3.23 |
Chicago | 227 | 3.17 |
Boston | 228 | 3.03 |
Kansas City | 193 | 2.97 |
San Francisco | 313 | 2.93 |
Denver | 176 | 2.61 |
Seattle | 203 | 2.34 |
Relative risk (high/low) | 2.20 | 1.52 |
Note—Table rows are ordered by descending relative value units per capita. Relative value units per capita are calculated by multiplying the procedures performed in a region by the total number of professional relative value units for the procedure and dividing by the regional denominator of eligible Medicare beneficiaries.
The trend lines in Figure 2 are mostly parallel, with few crossovers. By 2002, Dallas supplanted Philadelphia as the region with the second highest utilization rate. Atlanta remained the highest throughout, Seattle remained the lowest, and Denver remained the second lowest. Within the other five regions, bunched more closely together, there were more crossovers but no striking changes of relative position.
Differences in Categories Between Regions
Tables 3 and 4 present 2007 and 1998 utilization rates per 100,000 beneficiaries for noninvasive diagnostic imaging procedures grouped by the 28 category schema. Head PET was omitted in 1998 because it was reported in only one region. For each category, the high region rate, the low region rate, and the ratio between the two (relative risk), are listed, as well as the names of the high and low regions. The categories are ordered by relative risk, and the relative risk for all procedures is also included. We can think of procedure categories below the procedure average as low in variability, and those at 2.00 and above as high.
Procedure Group | High Rate | Low Rate | Relative Risk | High Region | Low Region |
---|---|---|---|---|---|
Bone densitometry | 8,851.2 | 6,844.3 | 1.29 | San Francisco | Seattle |
X-ray mammography | 24,787.5 | 18,182.7 | 1.36 | Boston | San Francisco |
X-ray skeletal | 83,991.1 | 61,137.2 | 1.37 | Atlanta | Seattle |
MRI musculoskeletal | 3,832.8 | 2,782.9 | 1.38 | Atlanta | Seattle |
CT body | 39,070.5 | 27,982.4 | 1.40 | Atlanta | Seattle |
MRI spine | 7,351.4 | 5,245.7 | 1.40 | Atlanta | Seattle |
CT spine | 2,700.6 | 1,886.5 | 1.43 | Kansas City | Seattle |
MRI head | 7,553.5 | 5,215.6 | 1.45 | Atlanta | Seattle |
CT head | 18,568.9 | 12,314.8 | 1.51 | Atlanta | Seattle |
Nuclear general | 5,360.1 | 3,204.8 | 1.67 | Atlanta | Seattle |
CT musculoskeletal | 966.6 | 571.4 | 1.69 | Boston | Seattle |
X-ray chest | 103,872.9 | 61,133.7 | 1.70 | Dallas | Seattle |
X-ray fluoroscopy | 3,565.4 | 2,027.2 | 1.76 | Atlanta | Seattle |
X-ray abdominal | 13,678.5 | 7,681.8 | 1.78 | Dallas | Seattle |
CT vascular | 3,076.4 | 1,633.3 | 1.88 | Denver | New York |
Ultrasound vascular | 25,454.0 | 13,490.4 | 1.89 | New York | Denver |
Ultrasound breast | 2,936.1 | 1,526.1 | 1.92 | New York | Kansas City |
Echo | 76,334.2 | 36,637.8 | 2.08 | New York | Seattle |
Nuclear cardiovascular | 28,803.3 | 13,820.3 | 2.08 | Atlanta | Seattle |
MRI body | 1,748.1 | 824.7 | 2.12 | New York | Denver |
Ultrasound general | 23,288.9 | 10,480.6 | 2.22 | New York | Denver |
Ultrasound obstetrical | 287.5 | 128.6 | 2.24 | Boston | San Francisco |
PET body | 1,755.8 | 765.0 | 2.30 | Atlanta | Seattle |
MRI vascular | 620.6 | 233.8 | 2.65 | New York | Seattle |
PET head | 33.0 | 8.0 | 4.13 | Dallas | Kansas City |
MRI cardiac | 77.3 | 10.8 | 7.12 | Denver | Kansas City |
CT cardiac | 602.5 | 78.4 | 7.69 | Dallas | Seattle |
PET cardiovascular | 117.4 | 1.7 | 70.20 | Atlanta | Seattle |
Note—Table rows are ordered by ascending values of the high rate/low rate relative risk.
Procedure Group | High Rate | Low Rate | Relative Risk | High Region | Low Region |
---|---|---|---|---|---|
X-ray skeletal | 72,210.4 | 54,961.5 | 1.31 | Atlanta | Seattle |
X-ray mammography | 22,607.5 | 16,789.4 | 1.35 | Boston | Dallas |
Ultrasound breast | 1,295.3 | 960.4 | 1.35 | Atlanta | Kansas City |
MRI spine | 3,126.9 | 2,181.9 | 1.43 | Atlanta | Boston |
Ultrasound vascular | 12,922.0 | 8,819.2 | 1.47 | Atlanta | Denver |
CT spine | 1,307.6 | 866.4 | 1.51 | Dallas | San Francisco |
CT head | 11,872.2 | 7,767.0 | 1.53 | Atlanta | Seattle |
CT musculoskeletal | 202.7 | 130.4 | 1.55 | Boston | Kansas City |
X-ray fluoroscopy | 6,828.3 | 4,375.4 | 1.56 | Atlanta | New York |
X-ray chest | 104,579.8 | 66,449.8 | 1.57 | Dallas | Seattle |
CT body | 17,705.7 | 11,018.6 | 1.61 | Philadelphia | Seattle |
X-ray abdominal | 16,642.1 | 10,135.2 | 1.64 | Atlanta | Seattle |
Nuclear general | 7,022.8 | 4,237.5 | 1.66 | Philadelphia | Seattle |
Bone densitometry | 4,661.2 | 2,748.5 | 1.70 | New York | Seattle |
Ultrasound general | 17,220.1 | 10,007.2 | 1.72 | New York | Denver |
MRI head | 3,672.7 | 2,074.8 | 1.77 | Philadelphia | Seattle |
MRI musculoskeletal | 1,323.4 | 743.3 | 1.78 | San Francisco | Denver |
Ultrasound obstetrical | 118.4 | 61.4 | 1.93 | Boston | Chicago |
Echo | 46,302.1 | 20,255.4 | 2.29 | New York | Seattle |
Nuclear cardiovascular | 11,478.7 | 4,295.2 | 2.67 | Atlanta | Seattle |
MRI body | 464.1 | 167.9 | 2.76 | New York | Kansas City |
MRI vascular | 38.4 | 5.3 | 7.27 | New York | Kansas City |
MRI cardiac | 5.6 | 0.4 | 13.09 | Chicago | New York |
PET body | 9.3 | 0.6 | 15.03 | New York | Dallas |
PET cardiovascular | 27.2 | 0.2 | 153.82 | Atlanta | Philadelphia |
Note—Table rows are ordered by ascending values of the high rate/low rate relative risk.
Table 3 shows large differences in regional variation across imaging categories in 2007. The three categories with lowest regional variation, as measured by relative risk, were bone densitometry, mammography, and skeletal radiography; all of them are radiographic procedures, two of which have strong screening components. However, six categories of advanced imaging—CT body, CT head, CT spine, MRI head, MRI musculoskeletal, and MRI spine—also fall below the mean relative risk. The 14 categories highest in regional variation, including 11 with relative risk > 2.00, are all advanced imaging techniques. Eight of the 14 highest variation categories are cardiovascular advanced imaging—CT cardiac, CT vascular, echo, MRI cardiac, MRI vascular, nuclear cardiovascular, PET cardiovascular, and ultrasound vascular. Ten of them are also high-growth categories—CT cardiac, CT vascular, echo, MRI body, MR cardiac, MRI vascular, nuclear cardiovascular, PET body, PET head, and PET cardiovascular.
It is instructive to compare regional variation across categories in 1998 (Table 4) with that in 2007. Regional variation across categories has grown in the last decade. The overall relative risk is lower in 1998 (1.49 vs 1.54), and there are fewer categories with relative risk > 2.00 in 1998 (7 vs 11). General ultrasound and breast ultrasound, low-cost advanced imaging techniques, have lower regional variation in 1998 than in 2007. Five of the advanced imaging techniques (CT body, CT head, CT spine, MRI head, and MRI musculoskeletal), which were in 2007 low variation procedures (below overall relative risk), were in the middle of the pack in 1998.
Discussion
Underlying regional variation in imaging utilization are concerns about cost and quality. Wide geographic variation in utilization raises questions about underutilization and quality on the low side and overutilization and costs on the high side. There are many factors involved in regional variation in utilization, including morbidity and risk factors in the population, access-to-care factors (e.g., the distribution of providers, physical barriers, and insurance issues), and general population factors (e.g., age, sex, race, education, and socioeconomic status). However, the most rational practice of medicine should presumably show as little variation as possible, declining to a floor level of variation caused by these factors.
This overview of geographic variation in radiology utilization is not reassuring. First, geographic variation is substantial. Over the last 10 years, the ratio of utilization in high and low regions has ranged from 1.47 to 1.56, with the last 5 years higher than the previous five. A relative risk of 1.5 is substantial; it means that one population has an excess of 50% in utilization over another. Generally, in epidemiology, relative risks > 1.2 draw researchers' attention. Differences in utilization between regions remain relatively stable, with no sign of lower utilization regions increasing relative to higher utilization regions.
Although a relative risk of 1.5 merits attention, it is quite different from the eight-fold difference in imaging costs between Vermont and Florida cited by Iglehart [6]. Which figure is more accurate to describe geographic variation in imaging practice? We calculated the relative risk on the basis of allowed charges and relative value units for procedures performed as well as utilization. The relative risk for relative value units, a measure of the complexity of the procedure performed, was 1.52 in 2007, almost exactly the same as the utilization relative risk of 1.54. The relative risk based on allowed charges is much higher (2.20). Regional comparisons of Medicare dollars spent on imaging are subject to a distortion based on the complex billing of radiology procedures. Both professional and technical charges are billed for radiology procedures, and the allowed technical charges (i.e., the reimbursement for the cost of equipment) dwarf the allowed professional charges (i.e., the reimbursement for doctor services). All allowed technical charges are reported in the Medicare Part B Physician Supplier Procedure Summary Master Files datasets for offices, but not for hospital outpatient or inpatient procedures. Thus, a different mix of office and hospital providers in different regions can yield very different relative risks for charges, compared with procedure counts, even when procedure counts are weighted by the complexity of the imaging performed. When the regions compared are very small (e.g., individual states), the variation between office and hospital providers, on top of differences in the underlying factors mentioned at the beginning of this discussion, can produce huge variations. It may be convenient for policy makers to pick out enormous differences to suggest that huge savings are available if one could just impose order on the chaos, but they are apt to be disappointed, because the differences, although large, are not huge. Furthermore, they can just as easily suggest underutilization on the low end as overutilization on the high end.
Bhargavan and Sunshine [24] painted a reassuring picture of regional differences and rates of change. They reported strongly negative relationships between regional utilization in 1998 and regional change from 1998 to 2001 (r = –0.951) and from 1995 to 2001 (r = –0.947), suggesting that higher utilization regions were leveling out. We certainly do not find this trend in the period 1998–2007. Relative risks are increasing yearly, there are almost no changes in relative position of regions over the period, and we find positive, though nonsignificant, correlations between either the starting or ending period and the rate of change.
Although a number of high-technology, high-cost imaging techniques have decreased in regional variation over the past 10 years, the number of categories of imaging techniques with relative risks > 2.0 have increased. We can discount some of the recently introduced, currently low-utilization categories, such as PET: newly introduced techniques will always show high variation because they are influenced by just a few early adopters in a region. The other high relative risks are composed entirely of advanced imaging categories, particularly cardiovascular advanced imaging. This finding is disturbing because cardiovascular imaging is performed predominantly in offices by cardiologists and is subject to self-referral issues [27]. Also troubling is the increase in variability of general ultrasound, a low-cost, high-technology imaging technique. Ultrasound is often described as an “operator-dependent” technique, and the increasing regional variation in utilization may suggest variation in distribution of highly trained personnel.
This study attempts to provide a high-level overview of regional variation in imaging utilization and has a number of limitations. It is based only on the fee-for-service Medicare population and may be limited in generalizability. Comparing utilization of more than 500 radiology procedures over 10 years and 10 regions forces very great analytic compression. It does not explore factors such as place of service or specialty of performing physician or the effect of the Deficit Reduction Act of 2005. Restricting the data source to the Physician Supplier Procedure Summary Master Files does not allow us to explore confounding factors, such as morbidity, demographics, or access. However, it seems very clear that there is substantial regional variation in imaging utilization, that this variation is not going away, and that it should be further explored.
Footnotes
Address correspondence to L. Parker ([email protected]).
This work was funded in part by the American College of Radiology.
References
1.
MedPAC. MedPAC recommendations on imaging services, statement of Mark E. Miller, Ph.D. before the Subcommittee on Health, Committee on Ways and Means, U.S. House of Representatives, March 17, 2005. www.medpac.gov/publications/congressional_testimony/031705_TestimonyImaging-Hou.pdf. Accessed January 29, 2010
2.
Maitino AJ, Levin DC, Parker L, Rao VM, Sunshine JH. Nationwide trends in rates of utilization of noninvasive diagnostic imaging among the Medicare population between 1993 and 1999. Radiology 2003; 227:113 –117
3.
Deficit Reduction Act of 2005, S.1932, Public Law 109-171 (2006). frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_cong_public_laws&docid=f:publ171.109.pdf. Accessed January 29, 2010
4.
Report to Congressional requesters: Medicare Part B imaging services: rapid spending growth and shift to physician offices indicate need for CMS to consider additional management practices. Washington, DC: Government Accountability Office, June 2008 (GAO-08-452)
5.
Pear R. Health care spending disparities stir a fight. New York Times, June 9,2009 : A17
6.
Iglehart JK. Health insurers and medical-imaging policy: a work in progress. N Engl J Med 2009; 360:1030 –1037
7.
Vandenbroucke JP. Changing images of John Snow in the history of epidemiology. Soz Praventivmed 2001; 46:288–293
8.
Terracini B, Zanetti R. A short history of pathology registries, with emphasis on cancer registries. Soz Praventivmed 2003; 48:3 –10
9.
Fisher E, Goodman D, Skinner J, Bronner K. Health care spending, quality and outcomes: more isn't always better. Hanover, NH: The Dartmouth Institute. February 7, 2009. www.dartmouthatlas.org/atlases/Spending_Brief_022709.pdf. Accessed August 8, 2009
10.
Santora LM, Mahoney MC, Lawvere S, Englert JJ, Symons AB, Mirand AL. Breast cancer screening beliefs by practice location. BMC Public Health 2003; 3:9
11.
Cooper GS, Yuan Z, Jethva RN, Rimm AA. Use of Medicare claims data to measure county-level variation in breast carcinoma incidence and mammography rates. Cancer Detect Prev 2002; 26:197 –202
12.
Legler J, Breen N, Meissner H, Malec D, Coyne C. Predicting patterns of mammography use: a geographic perspective on national needs for intervention research. Health Serv Res 2002; 37:929 –947
13.
Engelman KK, Hawley DB, Gazaway R, Mosier MC, Ahluwalia JS, Ellerbeck EF. Impact of geographic barriers on the utilization of mammograms by older rural women. J Am Geriatr Soc 2002; 50:62 –68
14.
Makuc DM, Breen N, Freid V. Low income, race, and the use of mammography. Health Serv Res 1999; 34:229–239
15.
Foster RS Jr, Farwell ME, Costanza MC. Breast-conserving surgery for breast cancer: patterns of care in a geographic region and estimation of potential applicability. Ann Surg Oncol 1995; 2:275 –280
16.
Rex DK, Lappas JC, Maglinte DD, Kelvin FM. Barium enema utilization within a defined geographic region: a survey. Gastrointest Radiol 1990; 15:265 –267
17.
Chalasani N, Horlander JC Sr, Said A, et al. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol 1999; 94:2988 –2993
18.
Saigal CS, Pashos CL, Henning JM, Litwin MS. Variations in use of imaging in a national sample of men with early-stage prostate cancer. Urology 2002; 59:400 –404
19.
Barbera L, Groome PA, Mackillop WJ, et al. The role of computed tomography in the T classification of laryngeal carcinoma. Cancer 2001; 91:394 –407
20.
Lurie JD, Birkmeyer NJ, Weinstein JN. Rates of advanced spinal imaging and spine surgery. Spine 2003; 28:616–620
21.
Wennberg DE, Kellett MA, Dickens JD, Malenka DJ, Keilson LM, Keller RB. The association between local diagnostic testing intensity and invasive cardiac procedures. JAMA 1996; 275:1161 –1164
22.
Chan B, Cox JL, Anderson G. Trends in the utilization of noninvasive cardiac diagnostic tests in Ontario from fiscal year 1989/90 to 1992/93. Can J Cardiol 1996; 12:237–248
23.
Rao VM, Parker L, Levin DC, Sunshine J, Bushee G Use trends and geographic variation in neuroimaging: nationwide medicare data for 1993 and 1998. AJNR 2001; 22:1643 –1649
24.
Bhargavan M, Sunshine JH. Utilization of radiology services in the United States: levels and trends in modalities, regions, and populations. Radiology 2005; 234:824–832
25.
Current procedural terminology. 4th ed. Chicago, IL: American Medical Association, 1999
26.
Healthcare Common Procedure Coding System (HCPCS). Centers for Medicare & Medicaid Services Website. www.cms.hhs.gov/hcpcsreleasecode-sets/02_hcpcs_quarterly_update.asp. Accessed January 20, 2010
27.
Levin, DC, Rao, VM, Parker, L, Frangos, AJ, Inenzo, CM. Recent payment and utilization trends in radionuclide myocardial perfusion imaging: comparison between self-referral and referral to radiologists. JACR 2009; 6:437 –441
Information & Authors
Information
Published In
Copyright
© American Roentgen Ray Society.
History
Submitted: August 25, 2009
Accepted: September 28, 2009
Keywords
Authors
Metrics & Citations
Metrics
Citations
Export Citations
To download the citation to this article, select your reference manager software.